2023
DOI: 10.5603/ahp.a2023.0026
|View full text |Cite
|
Sign up to set email alerts
|

CD2+ hairy cell leukemia

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2023
2023
2023
2023

Publication Types

Select...
1

Relationship

1
0

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 9 publications
0
1
0
Order By: Relevance
“…Second, at the outset, it is worth emphasizing that we have no concerns about the existence of immunophenotypic aberrancies in hematological diseases of the most diverse lineages. To take just a few examples, we have previously shown that some cases of Sézary syndrome, a T-cell disease, may express antigens of the natural-killer lineage (CD56, CD57, and granzyme B) (Matos et al, 2018) and that very rare cases of hairy cell leukemia, a B-cell disease, may express the CD2 antigen (Matos, 2023). Hence, we presume the existence of what have been imprecisely called "atypical" phenotypes of CLL, such as bright expression of CD20 or CD79b or even the unusual presence of T-cell antigens, such as CD8 (Matos, 2019).…”
Section: Dear Editormentioning
confidence: 99%
“…Second, at the outset, it is worth emphasizing that we have no concerns about the existence of immunophenotypic aberrancies in hematological diseases of the most diverse lineages. To take just a few examples, we have previously shown that some cases of Sézary syndrome, a T-cell disease, may express antigens of the natural-killer lineage (CD56, CD57, and granzyme B) (Matos et al, 2018) and that very rare cases of hairy cell leukemia, a B-cell disease, may express the CD2 antigen (Matos, 2023). Hence, we presume the existence of what have been imprecisely called "atypical" phenotypes of CLL, such as bright expression of CD20 or CD79b or even the unusual presence of T-cell antigens, such as CD8 (Matos, 2019).…”
Section: Dear Editormentioning
confidence: 99%